Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
91 participants
INTERVENTIONAL
2019-12-11
2025-06-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study proposes to evaluate a multidisciplinary patient care by insisting on anatomo-physiological pain management, psychological and bodily, in the perioperative phase.
The main objective is to evaluate benefit of psychological and corporal group management on the overall quality of life of patients with severe endometriosis in terms of endometriotic damage and/or functional and painful repercussions, requiring surgery, before or after this study
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sexual Health After Endometriosis Surgery
NCT03901885
Compliance and Endometriosis
NCT05619757
Quality of Life and Fertility of Patient With Deep Surgical Endometriosis: a Prospective Cohort
NCT03555903
Psychological Support Interventions for Women With Endometriosis (ENDOPSY)
NCT07280052
ENDometriosis: Evaluation of Detection and Need for ALGOlogic Care Before Surgery
NCT06997809
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients suffering from severe endometriosis and chronic pain
Patients suffering from severe endometriosis and chronic pain that have been identified during a gynecological consultation (individual or during a multidisciplinary team meetings) or during a pain consultation on the same site of the Croix-Rousse Hospital and having signed a consent form
Psychological and corporal group management
After inclusion, patient will be divided into groups of 6 or 8 patients either in pre-operative or post-operative phase. Patient care will take place entirely in pre-operative or post-operative phase.
Each group will benefit of six one hour and a half sessions.
The frequency is established as follows:
* First week a session of Body Strategy ©
* Second week a psychological session with group of speech (Photolanguage ©).
* Third week is a break Then the cycle currently described is repeated, for a total of 6 alternate sessions
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Psychological and corporal group management
After inclusion, patient will be divided into groups of 6 or 8 patients either in pre-operative or post-operative phase. Patient care will take place entirely in pre-operative or post-operative phase.
Each group will benefit of six one hour and a half sessions.
The frequency is established as follows:
* First week a session of Body Strategy ©
* Second week a psychological session with group of speech (Photolanguage ©).
* Third week is a break Then the cycle currently described is repeated, for a total of 6 alternate sessions
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with deep endometriosis according to the CNGOF (collège national des Gynécologues et Obstétriciens Français) and/or chronic pain related to endometriosis according to doctor's evaluation and to the definitions of IASP (International Association for the Study of Pain) and HAS (French National Authority for Health) in treatment failure despite appropriate medical or surgical management of endometriosis
* Patients with social security
* Patients willing to come to all study visits
* Patients who signed their informed consent
Exclusion Criteria
* Patients with social phobia assessed during the inclusion interview
* Patients with psychiatric disorders of a psychotic nature: delirium, hallucination, incoherent thoughts
* Patients with behavioral disorders of hetero-aggressive or self-aggressive type oPatients with a handicap that prevents them following the physical and psychological group sessions (speech disorders, hearing, visual or practical)
* Pregnant women
* Patients planning a change (stop, start) during the study of their psychological management in their current care path.
* Patients planning a change (stop, start) during the study of their treatment by non-medicinal techniques (auriculo-acupuncture, relaxation and self-hypnosis, transcutaneous neurostimulation by TENS)
* Patients suffering from other severe or chronic somatic diseases associated with endometriosis
* Patients with cognitive disorders
* Patients with analgesics addiction (psychoactive substances, morphine substances, etc.)
* Patients protected by law (under guardianship / trusteeship)
* Patients participating in another interventional research that may interfere with the protocol results
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patricia Branche, MD
Role: PRINCIPAL_INVESTIGATOR
Hospices Civils de Lyon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Croix Rousse Hospital
Lyon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-A02599-46
Identifier Type: OTHER
Identifier Source: secondary_id
69HCL18_0474
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.